ICPT - Intercept Pharma GAAP EPS of -$0.77 misses by $0.15 revenue of $68M misses by $4.68M April, 27 2023 07:08 AM Intercept Pharmaceuticals Inc. 2023-04-27 07:08:21 ET Intercept Pharma press release ( NASDAQ: ICPT ): Q1 GAAP EPS of -$0.77 misses by $0.15 . Revenue of $68M (+14.9% Y/Y) misses by $4.68M . For further details see: Intercept Pharma GAAP EPS of -$0.77 misses by $0.15, revenue of $68M misses by $4.68M